I am with you Twigman, a lot happening.
US presidential candidates haven't helped biotech confidence, but this novel approach to respiratory is compelling. I wouldn't rule out AstraZeneca after their disappointing phase 3 Incyte copd drug hasn't lived up to
expectations.
Ann: Response to ASX Appendix 4C Query-IVX.AX, page-11
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.63M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $282 | 140.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 18845222 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 8596961 | 49 |
View Market Depth
| Last trade - 10.44am 12/11/2024 (20 minute delay) ? |
| IVX (ASX) Chart |